2017 marks the fourth year of the World Heart Federation Emerging Leaders programme and will focus on access to essential medicines for cardiovascular diseases. Despite the availability for decades of evidence-based medicines to prevent and treat CVD, their use is still very low.
The Cardiovascular Genetics research team (led by Prof Bongani (dean of UCT’s Faculty of Health Sciences) and Dr Gasnat Shaboodien (Deputy Director of the Cardiovascular Genetics unit, HICRA, UCT) that discovered that a mutation in the CDH2 gene can cause a disease known as arrhythmogenic right ventricle cardiomyopathy (ARVC) has raised public awareness of heart disease in South Africa to a whole new level.
Dr Frederic Nduhirabandi, a postdoctoral researcher at the Hatter Institute, visited a European Research Council (ERC)-funded laboratory in Netherlands in the context of a newly initiated partnership between National Research Foundation (NRF) and ERC.
Johanna Ralston, CEO of the World Heart Federation made an announcement at its General Assembly which was held during the recent World Congress of Cardiology and Cardiovascular Heath 2016 that, Prof Karen Sliwa of South Africa has been elected by the membership as President-Elect of the Federation, marking two firsts: she is the first female president and the first from the African Continent.
Prof Sliwa, Dr Feriel Azibani (Post-doctoral Research fellow) & Olivia Briton (Project Coordinator) attended the 3rd World Congress on Acute Heart Failure, where Prof Sliwa presented the recently published results of the BAHEF study (European Journal of Heart Failure (2016)doi:10.1002/ejhf.581) in a Late Breaking Trial session as well as a talk on ‘Valvular disease in Pregnancy’ during the ‘Cardiac challenges in Pregnancy’ session.